COVID-19 vaccines may help protect kids from Long COVID

Embargoed until: Publicly released: 2025-02-25 03:00

International

SELF Magazine, https://www.flickr.com/photos/selfmagazine/48545962716/in/album-72157710332198661 https://creativecommons.org/licenses/by/2.0/

Vaccinating kids with mRNA COVID vaccines may help protect them against developing Long COVID, according to US research. The study of around 600 kids found that vaccination was associated with a 57% decreased odds of one or more Long COVID symptoms and a 73% decreased odds of two or more Long COVID symptoms. The authors say these findings suggest benefits of COVID-19 vaccination beyond protection against acute COVID-19 infection and may encourage increased uptake in kids.

Media release

From: JAMA

COVID-19 Vaccination and Odds of Post–COVID-19 Condition Symptoms in Children Ages 5 to 17

JAMA Network Open
Original Investigation

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

About The Study: The results of this study suggest that mRNA COVID-19 vaccination may be a protective factor against post–COVID-19 condition in children following SARS-CoV-2 infection. These findings suggest benefits of COVID-19 vaccination beyond those associated with protection against acute COVID-19 and may encourage increased pediatric uptake.

(doi:10.1001/jamanetworkopen.2024.59672)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: Centers for Disease Control and Prevention, USA

Funder: Funding was provided in whole or in part by federal funds from the National Center for Immunization and Respiratory Diseases, CDC, under contract Nos. 75D30122C14188 to University of Arizona and 75D30120C08150 awarded to Abt Associates, Inc.

Media Contact/s

Contact details are only visible to registered journalists.